CLS Investments »

Takeda Pharmaceutical shares owned by CLS Investments

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by CLS Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 79k 15.59
2025-09-30 $1.1M 72k 14.64
2025-06-30 $873k 56k 15.46
2025-03-31 $644k 43k 14.87
2024-12-31 $172k 13k 13.24

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)

View all positions for CLS Investments

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical